Thomas Reinke
The randomized controlled trial reigns supreme, but the FDA is working on ways to incorporate real-world evidence into its approval processes.
Victoria Sweet, MD
Peter Boland
In Slow Medicine, Victoria Sweet, MD, pulls the reader into a different reality, one that harkens back to an earlier era of one-on-one medicine, when physicians and patients commonly shared a bond of trust and familiarity. That era has faded with the emergence of systems of care and performance targets.
These eight questions show that the use of an LBM or a PAP should be just one of the potential results of your laboratory benefit management program, not the program itself. You shouldn’t have to pay for services you already provide yourselves or add a middleman that’s not necessary.

Career Opportunities

HAP, a subsidiary of Henry Ford Health System, is a nonprofit health plan providing coverage to individuals, companies and organizations. This executive develops strategies to meet membership and revenue targets through products, pricing, market segmentation and advertising.  Aligns business among Business Development, Commercial Sales, Medicare and Public Sector Programs and Product Development. Seeks to enhance and be responsible for business development and expansion through the development of an effective product portfolio, strong interpersonal relationships and service excellence.

Apply via email to or online at

News Wire

Lenses automatically darken in bright light
Researchers found no association between clinical value and cost
Test performed in the primary care setting may improve access to screening
Drug is first and only approved specific reversal agent for a novel oral anticoagulant
Regimen showed significant improvement in overall survival in trial versus Sutent
The winners among the Part D preferred pharmacy networks are willing to trade lower prescription profit margins for larger market share. CVS pharmacies are preferred in plans that enrolled 8.5 million people in 2018, compared with the fewer than 300,000 people enrolled in CVS retail pharmacies in 2017.
Frank Diamond
Deaths of women from opioid addiction spiked 400%, according to CDC data. Alison Colbert of Duquesne University argues for a gender-specific approach.
Richard Mark Kirkner
Social factors, like access to healthy food, stable housing, a steady income, and reliable transportation, may have more to do with a sick person getting well than anything that a health plan, doctor, or hospital can do. That’s been well documented by numerous studies and the likes of the World Health…

Social Determinants of Health Should Be Addressed, But That Will be Difficult

Our cover story explores the many issues and challenges involved, and looks at some success stories. For instance, the partnership of the ProMedica Health Care System in Toledo and philanthropist Russell Ebeid seems to be making real, concrete changes for the better in that city.

Still, it won’t be easy for providers and payers to tackle the “upstream” causes of poor health. Do they even want to? The story notes that clinicians are reluctant to add patient social needs to their responsibilities: social problems, let alone solving them, are not their area of expertise; the health care system already has more than enough to do in the medical realm without expanding its territory to take on social problems and needs; and there’s limited evidence that health care interventions can influence social determinants.


Orlando, FL
April 23, 2018 to April 24, 2018
Las Vegas
April 29, 2018 to May 2, 2018
Washington, DC
April 29, 2018 to May 2, 2018
Alexandria, Virginia
May 2, 2018 to May 3, 2018
May 17, 2018 to May 18, 2018
Orlando, FL
May 20, 2018 to May 22, 2018
May 21, 2018 to May 22, 2018
Zachary Hafner
It’s a must because there is a cost to keeping the underserved that way whether that means funding integrated primary care to help people live healthier lives or footing the bill when people get care in the emergency department.
Two men are the same age and they’ve both been diagnosed with type 2 diabetes. One was diagnosed 10 years before the other, though. The man with the earlier onset of type 2 diabetes has about a 30% to 60% greater risk of dying from any cause.
Lola Butcher
Providers and payers are being asked to tackle the ‘upstream’ causes of poor health. Medicaid managed care organizations are being asked to screen enrollees for social needs. Some targeted efforts have translated into cost savings and make sense in value-based arrangements. But are we asking the health sector to take on too much?